Dendreon Corp fka DNDNQ

[ocyanblue]

I agree. There are also factors related only to trial conduct that affects the analysis. For example, about 10% of the 9902a treatment arm did not get fully treated. That got to have some confounding effect on the final results. Hopefully IMPACT will do better with that. In addition, with a much larger enrollment number, the imbalances will be less pronounced.